Calquence

Generic name: acalabrutinib
Brand name: Calquence
Drug class: BTK inhibitors
Drug form: Oral capsules

Calquence (acalabrutinib) is an innovative medication that has significantly impacted the treatment landscape for certain blood cancers. As a Bruton’s tyrosine kinase (BTK) inhibitor, Calquence plays a crucial role in disrupting the growth and proliferation of cancerous B cells responsible for various blood malignancies. Since its approval by the FDA, Calquence has been a beacon of hope for many patients, offering an effective treatment option that targets the disease at a molecular level.

Overview of Calquence

Calquence, chemically known as acalabrutinib, belongs to a class of drugs known as BTK inhibitors. BTK, or Bruton’s tyrosine kinase, is an enzyme that plays a vital role in developing and surviving B cells, a type of white blood cell involved in the immune response. In certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL), these B cells become malignant and proliferate uncontrollably. By inhibiting the BTK enzyme, Calquence interferes with the signaling pathways these cancerous cells rely on, thereby reducing their growth and survival.

Learn More: Explore The Different Types of Cancer Treatment Options

Uses of Calquence

Chronic Lymphocytic Leukemia (CLL)

CLL is the most common type of leukemia in adults. This causes the slow accumulation of abnormal B cells in the blood, bone marrow, and lymphatic tissues. Calquence is used as a first-line treatment for CLL, either as a monotherapy or in combination with other drugs, such as obinutuzumab.

Small Lymphocytic Lymphoma (SLL)

SLL is closely related to CLL, with the primary difference being the location of the cancerous cells. While CLL affects the blood and bone marrow, SLL primarily involves the lymph nodes. Calquence effectively treats SLL by targeting the same malignant B cells responsible for the disease.

Mantle Cell Lymphoma (MCL)

Mantle cell lymphoma is a rare, fast-growing type of non-Hodgkin lymphoma that causes overproduction of B cells in the lymph nodes and other lymphatic tissues. Calquence treats MCL in patients who have received at least one prior therapy. The drug has been shown to induce significant responses in MCL patients, leading to prolonged remission in many cases.

Waldenström Macroglobulinemia (WM)

Waldenström macroglobulinemia is a rare type of non-Hodgkin lymphoma that produces large amounts of an abnormal protein called macroglobulin. This condition can lead to complications, including hyperviscosity syndrome, which thickens the blood and impairs circulation. Calquence targets the malignant B cells responsible for WM, helping to reduce the production of macroglobulin and alleviate symptoms.

Lymphoplasmacytic Lymphoma (LPL)

LPL is another rare cancer that affects the lymphatic system, causing the overproduction of abnormal lymphoplasmacytic cells. While it is closely related to WM, it can present a broader range of symptoms. Calquence is sometimes used to treat LPL, particularly in patients who have not responded to other therapies.

Side Effects of Calquence

Headache

One of the most frequently reported side effects of Calquence is headaches. These can vary in intensity from mild discomfort to severe, debilitating pain. Headaches may occur shortly after taking the medication or develop gradually over time. Patients experiencing persistent or severe headaches should consult their healthcare provider, as dosage adjustments or additional treatments may be necessary.

Diarrhea

Gastrointestinal disturbances, particularly diarrhea, are common among Calquence patients. If not appropriately managed, diarrhea can lead to dehydration and electrolyte imbalances. Patients are advised to stay hydrated and may require medications to control diarrhea if it becomes severe or persistent.

Muscle Pain

Calquence can cause muscle pain or joint discomfort, affecting the patient's quality of life. This side effect is typically mild but can be bothersome for some individuals. Over-the-counter pain relievers, such as acetaminophen or ibuprofen, may help alleviate this discomfort. However, patients should consult their healthcare provider before taking any additional medications.

Bruising or Bleeding

Because Calquence affects platelet function, it can increase the risk of bruising or bleeding, even with minor injuries. Patients should be cautious when engaging in activities that could result in cuts, bruises, or other injuries. Sometimes, healthcare providers may need to monitor platelet levels and adjust the dosage if bleeding becomes a concern.

Infections

Calquence can weaken the immune system, making patients more susceptible to infections. Common infections include upper respiratory infections, urinary tract infections, and pneumonia. Patients should be vigilant about signs of infection, such as fever, cough, or unusual fatigue, and seek medical attention promptly if they develop symptoms.

Check This Out: Explore Various Aspects Of Breast Cancer And It's Management

Warnings of Calquence

Increased Bleeding Risk

Calquence can significantly increase the risk of bleeding, particularly in patients who are taking anticoagulants (blood thinners) or have a history of bleeding disorders. Even minor injuries can result in excessive bleeding, which may require medical intervention. Patients should inform if they are taking any medications that affect blood clotting and report any unusual bleeding or bruising immediately.

Infections

Due to its immunosuppressive effects, Calquence can make patients more susceptible to infections, some of which may be serious or life-threatening. Patients should take precautions to avoid disease exposure, such as practicing good hygiene and avoiding close contact with sick individuals.

Heart Rhythm Problems

Calquence has been associated with atrial fibrillation and other heart rhythm disturbances, particularly in patients with pre-existing heart conditions. Atrial fibrillation can lead to symptoms such as palpitations, dizziness, chest pain, and shortness of breath. Patients with a history of heart problems should be closely monitored for these symptoms, and treatment may need to be adjusted if heart rhythm issues arise.

Liver Function

Calquence can affect liver function, particularly concerning patients with pre-existing liver conditions. Regular monitoring of liver enzymes is recommended during treatment to detect any potential liver damage early. Patients should report symptoms such as jaundice (yellowing of the skin or eyes), dark urine, or severe fatigue, which could indicate liver problems.

Gastrointestinal Issues

Calquence can cause significant side effects, including ulcers and gastrointestinal perforations, particularly in patients with GI issues. Symptoms such as severe abdominal pain, black or bloody stools, or vomiting blood should be treated as medical emergencies.

Before Taking Calquence

Some medicines can increase or decrease the levels of Calquence in the blood, leading to either increased side effects or reduced efficacy. Calquence is not recommended for use during pregnancy due to the potential for harm to the fetus. Women of childbearing age should use effective contraception while taking Calquence and for at least one week after the last dose. Additionally, breastfeeding is not recommended during treatment with Calquence, as it is unknown whether the drug passes into breast milk and what effects it may have on a nursing infant. Given the increased risk of infections, patients should take preventive measures to minimize their exposure to infectious agents. This includes practicing good hand hygiene, avoiding close contact with sick individuals, and keeping up-to-date with vaccinations.

Calquence Dosage

The dosage of Calquence is typically determined by the patient’s specific condition, overall health, and response to treatment. The standard dosage for most adult patients is 100 mg taken twice daily, approximately 12 hours apart. Calquence capsules should be swallowed whole with water and not opened, crushed, or chewed. Patients can take Calquence with or without food, but it is essential to take the doses consistently at the same times each day.

If a dose is missed, patients should take it as soon as they remember unless it is less than 3 hours until the next scheduled dose. In such cases, the missed dose should be skipped, and the next dose should be taken regularly. Doubling up on doses to make up for a missed one is not recommended.

Calquence Interactions

Potent CYP3A Inhibitors

Drugs that strongly inhibit the enzyme CYP3A can increase the levels of Calquence in the blood, leading to a higher risk of side effects. Examples include certain antifungal medications (e.g., ketoconazole), HIV protease inhibitors (e.g., ritonavir), and some antibiotics (e.g., clarithromycin).

Strong CYP3A Inducers

Conversely, drugs that strongly induce CYP3A can reduce Calquence's effectiveness by decreasing blood levels. Examples include certain anticonvulsants (e.g., phenytoin), rifampin (an antibiotic), and St. John’s wort (an herbal supplement). Patients taking these medications may require a different treatment approach.

Anticoagulants and Antiplatelet Drugs

Since Calquence increases the risk of bleeding, caution is required when used alongside blood-thinning medications such as warfarin, aspirin, and clopidogrel. The combined use of these drugs can further elevate the bleeding risk, necessitating close monitoring and possible dosage adjustments.

Grapefruit and Seville Oranges

Grapefruit and Seville oranges (often found in marmalades) can increase the levels of Calquence in the blood by inhibiting its metabolism. Patients are advised to avoid consuming these fruits and their juices during treatment.

Also Read: Chemotherapy for Cancer Treatment: Learn How It Works

Conclusion

Calquence (acalabrutinib) is a groundbreaking BTK inhibitor that has revolutionized the treatment of certain blood cancers, including CLL, SLL, and MCL. Its targeted mechanism of action and favorable side effect profile make it an invaluable option for patients who require effective and tolerable treatment. However, like all powerful medications, Calquence comes with its own set of risks, side effects, and interactions that must be carefully managed under the guidance of a healthcare provider.